Zymeworks (ZYME) Financials: Revenue & Earnings

ZYME price $28.97 +0.12 +0.42%

Ticker
ZYME
Price
$28.97
Change
+0.12 +0.42%
Market cap ?
$2.08B
P/E ?
-14.16
Forward P/E ?
28.05
Dividend yield ?
0.00%
Beta ?
1.17
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
45
Value
50
Quality
38
Growth
48

Stocklytics score rationale: value 50, quality 38, growth 48.

Financials

2016201720182019202020212022202320242025
1100900051762000530190002954400038951000266800004124820007601200076304000105965000

Zymeworks Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to identifying, advancing, and bringing to market biological therapies aimed at combating cancer. Its pipeline features two primary experimental treatments: zanidatamab, a cutting-edge bispecific antibody currently undergoing Phase 1 and Phase 2 studies for various malignancies such as those affecting the biliary tract…

Fair value

ZYME fair value $33.84. Price $28.97. Price is 14% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Compare ZYME

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-09—2.27—227.39M
2026-08-06-0.62-0.574.59M4.54M
2026-05-07-0.59-0.102.41M24.38M
2026-03-02-0.55-0.352.52M19.24M
2025-11-06-0.26-0.3027.61M19.49M
2025-08-070.03-0.5248.73M25.75M
2025-05-08-0.30-0.4527.11M18.02M
2025-03-05-0.310.0131.03M15.20M
2024-10-31-0.39-0.4016.00M47.07M
2024-08-01-0.49-0.4219.24M11.94M
2024-05-02-0.42-0.3110.03M17.52M
2024-03-06-0.20-0.3916.93M17.66M
2023-11-07-0.41-0.5516.51M14.63M
2023-08-10-0.76-0.517.00M29.38M
2023-05-08-0.37-0.6435.58M19.43M
2023-03-074.654.84402.49M214.37M
2022-11-08-0.72-0.942.63M3.94M
2022-08-04-0.97-0.935.44M7.09M
2022-05-04-1.19-0.971.92M—
2022-02-24-0.95-1.0619.87M8.06M
2021-11-03-1.25-1.184.39M7.75M
2021-08-04-1.31-1.061.77M7.10M
2021-05-05-0.87-1.02644.00K7.11M
2021-02-24-0.74-1.2115.68M10.30M
2020-11-03-1.43-0.922.64M12.72M
2020-08-05-0.63-0.8612.36M8.11M
2020-05-07-0.64-0.908.27M6.75M
2020-03-02-1.66-0.841.88M9.48M
2019-11-05-0.70-0.697.86M7.11M
2019-08-02-0.61-0.557.88M5.10M
2019-05-02-0.30-0.5211.93M6.88M
2019-03-060.290.1028.93M8.98M
2018-11-06-0.59-0.632.05M2.47M
2018-08-01-0.22-0.3522.00M20.67M
2018-05-01-0.83-0.6840.00K1.00M
2018-03-141.28-0.0250.07M16.73M
2017-11-08-0.65-0.74119.00K730.00K
2017-08-08-0.63-0.621.34M650.00K
2017-05-15-1.13—230.00K—
2017-04-28-0.57—2.23M—

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-09Schayowitz AdamSell37.04K——
2026-10-09Schayowitz AdamBuy37.04K——
2026-10-09Schayowitz AdamSell13.83K$25.85357.56K
2026-07-06Hollywood MarkBuy939$22.2220.86K
2026-05-13Schneider Paul RBuy178.00K$24.574.37M
2026-05-13Schneider Paul RBuy119.00K——
2026-05-13Schneider Paul ROther0——
2026-04-09Schayowitz AdamBuy76.00K——
2026-04-09Schayowitz AdamBuy70.00K$27.351.91M
2026-04-09Schayowitz AdamBuy47.00K——
2026-04-09Platshon ScottBuy76.00K——
2026-04-09Platshon ScottBuy70.00K$27.351.91M
2026-04-09Platshon ScottBuy47.00K——
2026-04-09Schayowitz AdamOther0——
2026-04-09Schayowitz AdamOther167.00K$16.922.83M
2026-04-09Schayowitz AdamOther111.11K——
2026-04-09Platshon ScottOther111.11K——
2026-04-09Platshon ScottOther167.00K$22.993.84M
2026-04-09Platshon ScottOther0——
2026-04-06Stafford KristinBuy178.00K$25.844.60M
2026-04-06Stafford KristinBuy119.00K——
2026-04-06Stafford KristinBuy50.00K——
2026-04-01Stafford KristinOther0——
2026-02-01Mekan SabeenOther0——
2026-02-01Mekan SabeenOther19.00K——
2026-02-01Mekan SabeenOther32.00K——
2026-02-01Mekan SabeenOther192.00K$11.752.26M
2026-02-01Mekan SabeenOther29.00K$23.16671.64K
2026-01-12Hollywood MarkBuy17.67K——
2026-01-12Hollywood MarkSell6.12K$22.67138.76K
2026-01-12Hollywood MarkBuy70.00K$23.161.62M
2026-01-12Hollywood MarkBuy66.00K——
2026-01-12Hollywood MarkBuy47.00K——
2026-01-12Hollywood MarkSell17.67K——
2026-01-12Cherry Brian NBuy23.00K$23.16532.68K
2026-01-12Cherry Brian NBuy15.40K——
2026-01-12Cherry Brian NOther0——
2026-01-12Smith Jeffrey T LBuy17.67K——
2026-01-12Smith Jeffrey T LSell17.67K——
2026-01-12Smith Jeffrey T LSell9.31K$22.67211.09K
2026-01-12Ciongoli Gregory AustinBuy11.50K$23.16266.34K
2026-01-12Ciongoli Gregory AustinBuy7.70K——
2026-01-12Neu KelvinBuy11.50K$23.16266.34K
2026-01-12Neu KelvinBuy7.70K——
2026-01-12Landry Robert EBuy11.50K$23.16266.34K
2026-01-12Landry Robert EBuy7.70K——
2026-01-12Cesano AlessandraBuy11.50K$23.16266.34K
2026-01-12Cesano AlessandraBuy7.70K——
2026-01-12Campoy CarlosBuy11.50K$23.16266.34K
2026-01-12Campoy CarlosBuy7.70K——
2026-01-12Mahony SusanBuy11.50K$23.16266.34K
2026-01-12Mahony SusanBuy7.70K——
2026-01-12Moore Paul AndrewBuy70.00K$23.161.62M
2026-01-12Moore Paul AndrewBuy66.00K——
2026-01-12Moore Paul AndrewBuy17.67K——
2026-01-12Moore Paul AndrewSell9.56K$22.67216.76K
2026-01-12Moore Paul AndrewBuy47.00K——
2026-01-12Moore Paul AndrewSell17.67K——
2026-01-12Galbraith KennethBuy64.00K——
2026-01-12Galbraith KennethSell30.42K$22.67689.82K
2026-01-12Galbraith KennethBuy222.00K——
2026-01-12Galbraith KennethBuy216.00K$23.165.00M
2026-01-12Galbraith KennethBuy144.00K——
2026-01-12Galbraith KennethSell64.00K——
2026-01-09Hollywood MarkOther0——
2026-01-09Hollywood MarkOther61.00K$8.00488.00K
2026-01-09Hollywood MarkOther90.00K$7.00630.00K
2026-01-09Hollywood MarkOther80.00K$15.231.22M
2026-01-09Hollywood MarkOther79.00K$13.221.04M
2026-01-09Hollywood MarkOther24.38K$35.20858.00K
2026-01-09Hollywood MarkOther30.00K$34.821.04M
2026-01-09Hollywood MarkOther53.00K——
2026-01-09Hollywood MarkOther90.00K$10.56950.40K
2026-01-06PATTERSON LEONE DBuy459$10.554.84K
2026-01-05Smith Jeffrey T LBuy20.00K——
2026-01-05Smith Jeffrey T LSell20.00K——
2026-01-05Smith Jeffrey T LSell10.54K$25.10264.47K
2026-01-05Galbraith KennethBuy66.67K——
2026-01-05Galbraith KennethSell31.69K$25.10795.22K
2026-01-05Galbraith KennethBuy47.67K——
2026-01-05Galbraith KennethSell22.66K$25.10568.62K
2026-01-05Galbraith KennethSell66.67K——
2026-01-05Galbraith KennethSell47.67K——
2026-01-05Moore Paul AndrewBuy20.00K——
2026-01-05Moore Paul AndrewBuy17.17K——
2026-01-05Moore Paul AndrewSell10.82K$25.10271.57K
2026-01-05Moore Paul AndrewSell9.29K$25.10233.13K
2026-01-05Moore Paul AndrewSell20.00K——
2026-01-05Moore Paul AndrewSell17.17K——
2025-12-22Galbraith KennethBuy100.00K——
2025-12-22Galbraith KennethSell47.53K$27.021.28M
2025-12-22Galbraith KennethSell100.00K——
2025-08-12Ciongoli Gregory AustinBuy415.00K$12.024.99M
2025-08-11Ciongoli Gregory AustinBuy62.00K$12.44771.28K
2025-08-11Landry Robert EBuy62.00K$12.44771.28K
2025-08-10Landry Robert EOther0——
2025-08-10Ciongoli Gregory AustinOther0——
2025-08-10Ciongoli Gregory AustinOther0——
2025-08-10Ciongoli Gregory AustinOther0——
2025-06-26EcoR1 Capital, LLCBuy5.09M$0.00509

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 208, holders -14 vs prior quarter. Ownership 93.87%.

HolderSharesChangeChange %Value
ECOR1 CAPITAL, LLC22.97M00.00%600.45M
RUBRIC CAPITAL MANAGEMENT LP7.00M00.00%182.98M
BLACKROCK, INC.4.25M-302.86K-6.65%111.12M
PERCEPTIVE ADVISORS LLC4.18M672.88K+19.17%109.34M
BVF INC/IL3.65M-85.00K-2.28%95.39M
MORGAN STANLEY2.23M-249.31K-10.05%58.33M
BNP PARIBAS ASSET MANAGEMENT HOLDING S.A.1.78M-126.92K-6.65%46.56M
VANGUARD CAPITAL MANAGEMENT LLC1.56M-146.58K-8.59%40.75M
ASSENAGON ASSET MANAGEMENT S.A.1.25M524.04K+71.99%32.73M
NEXTECH INVEST LTD.1.11M00.00%29.12M
STATE STREET CORP1.09M76.44K+7.55%28.45M
DIMENSIONAL FUND ADVISORS LP994.96K-144.18K-12.66%26.00M
CITADEL ADVISORS LLC914.14K827.04K+949.52%23.90M
NOMURA ASSET MANAGEMENT INTERNATIONAL INC.889.80K889.80KNew23.26M
FMR LLC702.57K35.41K+5.31%18.37M
GEODE CAPITAL MANAGEMENT, LLC692.41K32.47K+4.92%18.10M
PROSIGHT MANAGEMENT, LP674.43K135.38K+25.12%17.63M
QUBE RESEARCH & TECHNOLOGIES LTD593.59K81.65K+15.95%15.52M
VANGUARD PORTFOLIO MANAGEMENT LLC510.03K10.16K+2.03%13.33M
REDMILE GROUP, LLC491.65K00.00%12.85M
CAPRICORN FUND MANAGERS LTD486.53K-520.68K-51.70%12.72M
GOLDMAN SACHS GROUP INC470.82K-128.66K-21.46%12.31M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP418.50K-325.40K-43.74%10.94M
DEUTSCHE BANK AG\397.19K-524.06K-56.89%10.38M
HILLSDALE INVESTMENT MANAGEMENT INC.382.92K37.30K+10.79%10.01M

Earnings and financials

Zymeworks Inc. (ZYME) trades at $28.97, with a market cap of $2.08B and a trailing P/E of -14.16. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2016201720182019202020212022202320242025
1100900051762000530190002954400038951000266800004124820007601200076304000105965000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Zymeworks (ZYME) Financials: Revenue & Earnings

ZYME$28.97+0.12 +0.42%

$2.08B

Market Cap

-14.16

P/E

28.05

Forward P/E

45

Score

Price History